Published in Crit Rev Immunol on January 01, 2005
Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer (2007) 1.63
Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One (2011) 1.24
Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9. J Am Chem Soc (2008) 0.91
Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer. Int J Exp Pathol (2010) 0.87
Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas. Int J Clin Oncol (2012) 0.80
Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer (2010) 0.79
Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer. Dig Dis Sci (2012) 0.78
Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion. Br J Pharmacol (2017) 0.75
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies. Int J Mol Sci (2016) 0.75
Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy. Eur J Pediatr (2011) 0.75
Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem (2002) 1.32
Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol (2008) 1.24
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin Cancer Res (2010) 1.19
Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells. Am J Pathol (2010) 1.13
Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin Ther Targets (2004) 1.10
Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells. Cancer Res (2012) 1.09
A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res (2005) 1.03
ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur J Immunol (2003) 1.02
Pan-Arctic distributions of continental runoff in the Arctic Ocean. Sci Rep (2013) 1.01
Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol (2004) 1.01
MMP-9 expression varies according to molecular subtypes of breast cancer. BMC Cancer (2014) 1.00
Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun (2002) 0.99
The structural origin of second harmonic generation in fascia. Biomed Opt Express (2010) 0.98
Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model. Cancer Res (2007) 0.96
Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation. J Rheumatol (2007) 0.96
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem Biophys Res Commun (2004) 0.90
History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada. Ann Allergy Asthma Immunol (2010) 0.90
Epigenetic regulation of mmp-9 gene expression. Cell Mol Life Sci (2012) 0.90
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. J Cell Physiol (2008) 0.89
PKC isoforms interact with and phosphorylate DNMT1. BMC Biol (2011) 0.89
Effect of Ly49 haplotype variance on NK cell function and education. J Immunol (2010) 0.88
Expression of galectin-7 is induced in breast cancer cells by mutant p53. PLoS One (2013) 0.88
Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination. Pediatr Allergy Immunol (2007) 0.87
Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation. Biochem Biophys Res Commun (2009) 0.87
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol (2009) 0.87
Phosphorylation of human DNMT1: implication of cyclin-dependent kinases. Biochem Biophys Res Commun (2011) 0.85
EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth. Blood (2010) 0.85
Analysis of the mouse 129-strain Nkrp1-Clr gene cluster reveals conservation of genomic organization and functional receptor-ligand interactions despite significant allelic polymorphism. Immunogenetics (2011) 0.85
The role of DNA hypomethylation in the control of stromelysin gene expression. Biochem Biophys Res Commun (2006) 0.85
Induced expression of MMP-9 in C6 glioma cells is inhibited by PDGF via a PI 3-kinase-dependent pathway. Biochem Biophys Res Commun (2002) 0.84
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats. Peptides (2005) 0.84
Rapid antimicrobial susceptibility testing of urinary tract isolates and samples by flow cytometry. J Med Microbiol (2002) 0.83
Bidirectional interactions between bone metabolism and hematopoiesis. Exp Hematol (2011) 0.82
Novel kinin B1 receptor agonists with improved pharmacological profiles. Peptides (2008) 0.80
Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma. Blood (2005) 0.79
Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am J Hypertens (2008) 0.78
Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model. Cell Mol Life Sci (2011) 0.78
5-Aza-2'-deoxycytidine and interleukin-1 cooperate to regulate matrix metalloproteinase-3 gene expression. Int J Cancer (2011) 0.77
Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells. Biochem Biophys Res Commun (2003) 0.77
The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy. J Pathol (2014) 0.76
Climate change enhances primary production in the western Antarctic Peninsula. Glob Chang Biol (2015) 0.76
A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis. Arthritis Res Ther (2006) 0.75
Transcriptome profile within the mouse central nervous system and activation of myelin-reactive T cells following murine coronavirus infection. J Neuroimmunol (2005) 0.75
Expression and functions of galectin-7 in human and murine melanomas. PLoS One (2013) 0.75
[Galectin-7: a novel gene associated with metastasis]. Med Sci (Paris) (2005) 0.75
Potential directions for drug development against galectin-7 in cancer. Expert Opin Drug Discov (2009) 0.75
Lymphoma cells contribute to the augmentation of plasma sL-selectins in the serum of lymphoma-bearing mice. Leuk Lymphoma (2010) 0.75